Oxford MicroMedical Ltd (OMM) was formed in September 2012 to develop a medical breath testing system to detect the presence of Helicobacter pylori infection (H. pylori).
This bacterial infection of the stomach is widespread throughout the world and is particularly prevalent in developing countries.
H. pylori is now known as the principal agent in the formation of stomach ulcers and ultimately stomach cancer.
There is consequently a strong demand for a reliable, cheap and portable test for H. pylori infection.
Once reliably identified, the infection can be successfully treated using the so-called Triple Therapy involving two antibiotics and an antacid drug.
Oxford Micro Medical 